Alzheimer’s Drug Discovery Foundation: Treat Frontotemporal Degeneration Fund – clinical trials for frontotemporal degeneration

The Alzheimer’s Drug Discovery Foundation and the Association of Frontotemporal Degeneration, under the Treat Frontotemporal Degeneration fund, invite letters of intent for their clinical trials for frontotemporal degeneration (FTD) . This supports innovative clinical trials testing novel or re-purposed drugs for frontotemporal degeneration and related disorders. Trials should address both genetic and sporadic forms of FTD and related disorders, including behavioural variant FTD, primary progressive aphasia, corticobal syndrome, amyotrophic lateral sclerosis.

Funding & Duration

Grants are worth between USD $500,000 and $2M each (approx. AUD $706,000 and $2.8M), for a period of one to three years.


Private and public non-profit and for-profit institutions may apply. Partnerships and co-funding with industry are accepted. Leveraging of existing resources, clinical coordination centres or networks and patient registries are highly encouraged.

Submission Requirements & Due Dates

Further Information

Need Help?

This entry was posted in Funding by Award Type, Funding by Faculty, Grants (Project Funds), Health & Medical Sciences, International Funding. Bookmark the permalink.

Comments are closed.